The Debtor has been advised post-petition that it has been awarded four patents for various aspects of that program, and filed to validate one of those patents issued by the European Union in the United Kingdom and eight member states of the EU.
It also completed a pilot animal study and began collecting and evaluating data from that research. The Debtor has also continued to purse grant money which, if awarded, could provide additional funding to the Debtor. $BRTXQ
News 
Market Data 
Discover 
